首页> Frontiers in immunology> Neutralizing Antibody Responses to SARS-CoV-2 in Recovered COVID-19 Patients Are Variable and Correlate With Disease Severity and Receptor-Binding Domain Recognition.

Neutralizing Antibody Responses to SARS-CoV-2 in Recovered COVID-19 Patients Are Variable and Correlate With Disease Severity and Receptor-Binding Domain Recognition.

导出 LinkOut

翻译打印收藏纠错

第一作者： Agnieszka Katarzyna,Maciola

第一单位： Laboratory of Synthetic Immunology, Oncology and Immunology Section, Department of Surgery Oncology and Gastroenterology, University of Padua, Padua, Italy.

作者： Agnieszka Katarzyna,Maciola ^[1] ; Massimo,La Raja ^[2] ; Monia,Pacenti ^[3] ; Cristiano,Salata ^[4] ; Giustina,De Silvestro ^[2] ; Antonio,Rosato ^[5] ; Giulia,Pasqual ^[6]

作者单位： Laboratory of Synthetic Immunology, Oncology and Immunology Section, Department of Surgery Oncology and Gastroenterology, University of Padua, Padua, Italy. ^[1] Department of Transfusion Medicine, Padua University Hospital, Padua, Italy. ^[2] Institute of Microbiology and Virology, Padua University Hospital, Padua, Italy. ^[3] Department of Molecular Medicine, University of Padua, Padua, Italy. ^[4] Oncology and Immunology Section, Department of Surgery Oncology and Gastroenterology, University of Padua, Padua, Italy.;Veneto Institute of Oncology IOV-IRCCS, Padua, Italy. ^[5] Laboratory of Synthetic Immunology, Oncology and Immunology Section, Department of Surgery Oncology and Gastroenterology, University of Padua, Padua, Italy.;Veneto Institute of Oncology IOV-IRCCS, Padua, Italy. ^[6]

关键词 COVID-19 SARS-CoV-2 antibodies humoral response neutralization